Treatment Efficacy with Bone Marrow Derived Mesenchymal Stem Cells and Minocycline in Rats After Cerebral Ischemic Injury

Stem Cell Reviews and Reports

Volumn 9, Issue 2, 2013, Pages 219-225

  Bilen, Sule ^a   Pinarli, Ferda ^b   Ak, Fikri ^a   Fadillioglu, Ersin ^c   Albayrak, Aynur ^b   Boyuk, Gulbahar ^b   Guler, Osman Gokhan ^b   Erden, Gonul ^b   Ulus, A Tulga ^d   Delibasi, Tuncay ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Ankara Yuksek Ihtisas Education and Research Hospital   (Turkey)

Author keywords

Bone marrow derived mesenchymal stem cell; Cerebral ischemic injury; Functional improvement; Minocycline

Indexed keywords

ANIMALIA; RATTUS;

EID: 84875621409     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9422-3     Document Type: Article

References (23)

1. Jablonska, A., & Lukomska, B. (2011). Stroke induced brain changes: implications for stem cell transplantation. Acta Neurobiologiae Experimentalis, 71, 74-85.
2. Horie, N., Pereira, M. P., Niizuma, K., et al. (2011). Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells, 29, 274-285.
3. Vora, N., Jovin, T., & Kondziolka, D. (2006). Cell transplantation for ischemic stroke. Neurodegenerative Diseases, 3(1-2), 101-105.
4. Bacigaluppi, M., Pluchino, S., Martino, G., et al. (2008). Neural stem/precursor cells for the treatment of ischemic stroke. Journal of Neurological Sciences, 265(1-2), 73-77.
5. Guzman, R., Choi, R., Gera, A., Los Angeles, A. De, et al. (2008). Intravascular cell replacement therapy for stroke. Neurosurgical Focus, 24(3-4), E15.
6. Bhasin, M. V. A., Srivastava, P., Kumaran, S. S., et al. (2011). Autologous mesenchymal stem cells in chronic stroke. Cerebrovascular Diseases Extra, 1, 93-104.
7. Dharmasaroja, P. (2009). Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. Journal of Clinical Neuroscience, 16, 12-20.
8. Nomura, T., Honmou, O., Harada, K., et al. (2005). I. V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience, 136(1), 161-169.
9. Horita, Y., Honmou, O., Harada, K., et al. (2006). Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. Journal of Neuroscience Research, 84(7), 1495-1504.
10. Hicks, A., & Jolkkonen, J. (2009). Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiologiae Experimentalis, 69, 1-10.
11. Fox, C., Dingman, A., Derugin, N., et al. (2005). Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. Journal of Cerebral Blood Flow and Metabolism, 25(9), 1138-1149.
12. Rueger, M. A., Muesken, S., Walberer, M., et al. (2012). Effects of minocycline on endogenous neural stem cells after experimental stroke. Neuroscience, 26(215), 174-183.
13. Bederson, J. B., Pitts, L. H., Tsuji, M., et al. (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke, 17, 472-476.
14. Ma, L., Scheers, W., & Vandenberghe, P. (2004). A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral blood. Journal of Immunological Methods, 285(2), 215-221.
15. Joyce, N., Annett, G., Wirthlin, L., et al. (2010). Mesenchymal stem cells for the treatment of neurodegenerative disease. Regenerative Medicine, 5(6), 933-946.
16. Tikka, T. M., & Koistinaho, J. E. (2001). Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. Journal of Immunology, 166, 7527-7533.
17. Tikka, T. M., Vartiainen, N. E., Goldsteins, G., et al. (2002). Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain, 125, 722-731.
18. Jin, K., Sun, Y., Xie, L., et al. (2005). Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiology of Disease, 18(2), 366-374.
19. Keum, S. B., & Joon, B. P. (2011). Neuron-like differentiation of bone marrow-derived mesenchymal stem cells. Yonsei Medical Journal, 52(3), 401-412.
20. Liu, Z., Fan, Y., Won, S. J., et al. (2007). Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke, 38, 146-152.
21. Tang, X. N., Wang, Q., Koike, M. A., et al. (2007). Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia. Journal of Nuclear Medicine, 48(11), 1822-1828.
22. Omori, Y., Honmou, O., Harada, K., et al. (2008). Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Research, 1236, 30-38.
23. Ma, T. (2010). Mesenchymal stem cells: from bench to bedside. World Journal of Stem Cells, 2(2), 13-17.